Home › Funds › Vanguard Group › BEAM
Vanguard Group position in BEAM
BEAM THERAPEUTICS INC · Health Care
Latest position (Q4 2025)9.19M sh
Reported value held$254.84M
Portfolio Weight0.00%
First reportedQ1 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2021 | 3.23M | $258.80M | New |
| Q2 2021 | 3.44M | $442.19M | Add |
| Q3 2021 | 4.52M | $393.00M | Add |
| Q4 2021 | 4.70M | $374.32M | Add |
| Q1 2022 | 4.71M | $270.00M | Hold |
| Q2 2022 | 5.25M | $203.09M | Add |
| Q3 2022 | 6.17M | $294.15M | Add |
| Q4 2022 | 6.27M | $245.36M | Add |
| Q1 2023 | 6.39M | $195.52M | Add |
| Q2 2023 | 7.01M | $223.83M | Add |
| Q3 2023 | 6.81M | $163.90M | Reduce |
| Q4 2023 | 7.16M | $195.03M | Add |
| Q1 2024 | 7.58M | $250.40M | Add |
| Q2 2024 | 7.90M | $185.11M | Add |
| Q3 2024 | 7.84M | $192.19M | Reduce |
| Q4 2024 | 7.62M | $189.03M | Reduce |
| Q1 2025 | 8.87M | $173.26M | Add |
| Q2 2025 | 9.71M | $165.10M | Add |
| Q3 2025 | 9.25M | $224.52M | Reduce |
| Q4 2025 | 9.19M | $254.84M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BEAM
- Fidelity Management & Research (FMR) 12.61M sh · $432.74M · Q2 2026
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- BlackRock Inc 9.00M sh · $308.80M · Q2 2026
- Geode Capital Management 2.60M sh · $89.14M · Q2 2026
- Morgan Stanley 1.95M sh · $66.96M · Q2 2026
- Two Sigma Investments 1.39M sh · $47.64M · Q2 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Goldman Sachs Group 1.31M sh · $44.96M · Q2 2026
- Northern Trust Corp 933.48K sh · $32.04M · Q2 2026
- Charles Schwab Investment Management 885.90K sh · $30.40M · Q2 2026